These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro and in vivo effects of SCA40 on guinea pig airways. Buchheit KH, Hofmann A, Pfannkuche HJ. Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):217-23. PubMed ID: 9050015 [Abstract] [Full Text] [Related]
3. Atypical effect of minoxidil sulphate on guinea pig airways. Buchheit KH, Hofmann A, Manley P, Pfannkuche HJ, Quast U. Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):418-24. PubMed ID: 10763857 [Abstract] [Full Text] [Related]
4. Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways. Chapman ID, Kristersson A, Mathelin G, Schaeublin E, Mazzoni L, Boubekeur K, Murphy N, Morley J. Br J Pharmacol; 1992 Jun; 106(2):423-9. PubMed ID: 1382782 [Abstract] [Full Text] [Related]
5. Evaluation of the potassium channel activator BRL 38227 as an inhaled bronchodilator in the guinea-pig: contrast with nifedipine and salbutamol. Bowring NE, Buckle DR, Clarke GD, Taylor JF, Arch JR. Pulm Pharmacol; 1991 Jun; 4(2):99-105. PubMed ID: 1804502 [Abstract] [Full Text] [Related]
6. Evaluation of the novel potassium channel activator BRL 55834 as an inhaled bronchodilator in guinea-pigs and rats: comparison with levcromakalim and salbutamol. Arch JR, Bowring NE, Buckle DR. Pulm Pharmacol; 1994 Apr; 7(2):121-8. PubMed ID: 8081072 [Abstract] [Full Text] [Related]
7. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects. Buchheit KH, Manley PW, Quast U, Russ U, Mazzoni L, Fozard JR. Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918 [Abstract] [Full Text] [Related]
8. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats. Bowring NE, Arch JR, Buckle DR, Taylor JF. Br J Pharmacol; 1993 Aug; 109(4):1133-9. PubMed ID: 8401925 [Abstract] [Full Text] [Related]
9. The effect of inhaled K+ channel openers on bronchoconstriction and airway microvascular leakage in anaesthetised guinea pigs. Kidney JC, Lotvall JO, Lei Y, Chung KF, Barnes PJ. Eur J Pharmacol; 1996 Jan 18; 296(1):81-7. PubMed ID: 8720480 [Abstract] [Full Text] [Related]
10. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure. Ando T, Kume H, Urata Y, Takagi K. Clin Exp Allergy; 1997 Jun 18; 27(6):705-13. PubMed ID: 9208193 [Abstract] [Full Text] [Related]
11. Actions of SDZ PCO 400 and cromakalim on airway smooth muscle in vivo. Chapman ID, Mazzoni L, Morley J. Agents Actions Suppl; 1991 Jun 18; 34():53-62. PubMed ID: 1793082 [Abstract] [Full Text] [Related]
12. Salbutamol-induced airway hyperreactivity in guinea pigs is not due to a loss of its bronchodilator effect. Buchheit KH, Hofmann A, Fozard JR. Eur J Pharmacol; 1995 Dec 04; 287(1):85-8. PubMed ID: 8666031 [Abstract] [Full Text] [Related]
13. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig. Imagawa J, Kamei K, Yoshida S, Sugo I, Koga T, Nabata H. J Pharmacol Exp Ther; 1994 Apr 04; 269(1):1-6. PubMed ID: 8169816 [Abstract] [Full Text] [Related]
14. Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig. Paciorek PM, Cowlrick IS, Perkins RS, Taylor JC, Wilkinson GF, Waterfall JF. Br J Pharmacol; 1990 Jun 04; 100(2):289-94. PubMed ID: 2379034 [Abstract] [Full Text] [Related]
15. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers. Lawson K, Barras M, Zazzi-Sudriez E, Martin DJ, Armstrong JM, Hicks PE. Br J Pharmacol; 1992 Sep 04; 107(1):58-65. PubMed ID: 1422579 [Abstract] [Full Text] [Related]
16. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE. Br J Pharmacol; 1994 Dec 04; 113(4):1423-31. PubMed ID: 7889300 [Abstract] [Full Text] [Related]
17. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE. Dan Med Bull; 1996 Dec 04; 43(5):429-47. PubMed ID: 8960816 [Abstract] [Full Text] [Related]
18. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Yao Z, Gross GJ. Circulation; 1994 Apr 04; 89(4):1769-75. PubMed ID: 8149542 [Abstract] [Full Text] [Related]
19. Allergic responses reduce the relaxant effect of beta-agonists but not potassium channel openers in guinea-pig isolated trachea. Houjou S, Iizuka K, Dobashi K, Nakazawa T. Eur Respir J; 1996 Oct 04; 9(10):2050-6. PubMed ID: 8902466 [Abstract] [Full Text] [Related]
20. Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs: in vitro and in vivo studies. Englert HC, Wirth K, Gehring D, Fürst U, Albus U, Scholz W, Rosenkranz B, Schölkens BA. Eur J Pharmacol; 1992 Jan 07; 210(1):69-75. PubMed ID: 1601049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]